BPC-157 Dosage Guide: Protocols, Timing, and Safety [2026]

What Is the Standard BPC-157 Dose?

The standard BPC-157 dose used across most preclinical research is 10mcg per kg of body weight per day, which translates to approximately 200 to 500mcg daily for a typical adult when extrapolated using allometric scaling. A 2018 review in Current Pharmaceutical Design analyzing over 30 animal studies confirmed that this dose range produced consistent therapeutic effects across tissue types including tendon, muscle, gut, and nerve tissue.

In practice, most peptide therapy clinics prescribe BPC-157 at 250 to 500mcg per day as a starting dose. The lower end (250mcg) is typically used for general recovery and maintenance purposes, while the higher end (500mcg) is reserved for active injuries or more aggressive healing protocols. Some clinicians split the daily dose into two injections (morning and evening) for sustained tissue exposure.

It is important to understand that these doses are extrapolated from animal data and clinical experience, not from controlled human dose-finding studies. Individual response varies, and your prescribing provider may adjust your dose based on your specific condition, body weight, and observed response.

How Should You Adjust BPC-157 Dose by Body Weight?

Using the 10mcg/kg reference from animal research provides a straightforward way to scale BPC-157 dosing by body weight. A 2016 study in the Journal of Physiology and Pharmacology used this ratio consistently across multiple injury models and found reliable dose-response relationships. Allometric scaling from rat to human doses suggests a conversion factor of approximately 6.2, meaning the effective human dose per kg is lower than the rat dose.

The body weight dosing table below applies the research-referenced ratio to common adult weights. These are starting points, not rigid prescriptions. Individual factors including severity of condition, administration route, and concurrent medications all influence the optimal dose.

How Do You Reconstitute BPC-157?

BPC-157 is supplied as a lyophilized (freeze-dried) powder in vials typically containing 5mg or 10mg of peptide. Reconstitution requires adding bacteriostatic water (BAC water) to dissolve the powder into an injectable solution. The amount of water you add determines the concentration, which in turn determines how much liquid you draw up for each dose.

The most common reconstitution for a 5mg vial is 2mL of BAC water, which produces a concentration of 2.5mg per mL (2,500mcg per mL). At this concentration, a 250mcg dose equals 0.1mL or 10 units on a standard 100-unit insulin syringe. This makes dosing simple and precise.

To reconstitute, draw 2mL of BAC water into a syringe, inject it slowly down the side of the peptide vial (do not spray directly onto the powder), and gently swirl until the powder is fully dissolved. Do not shake the vial. The reconstituted solution should be clear and colorless.

Store it refrigerated at 2 to 8 degrees Celsius and use within 28 days.

Where Should You Inject BPC-157?

Subcutaneous injection is the most common administration route for BPC-157. The standard recommendation in peptide therapy practice is to inject as close to the site of injury or target area as possible, based on the rationale that local delivery concentrates the peptide near the tissue that needs repair. However, systemic distribution occurs regardless of injection site, so abdominal injections are acceptable for general use.

Common injection sites include the lower abdomen (2 inches from the navel), the fatty tissue near an injured joint or tendon, the upper thigh, and the upper arm. Rotate injection sites to prevent lipodystrophy (changes in fat tissue) from repeated injections in the same location. Use a 29 to 31 gauge insulin syringe with a half-inch needle for subcutaneous delivery.

Proper injection technique involves cleaning the site with an alcohol swab, pinching a fold of skin, inserting the needle at a 45-degree angle, injecting slowly, and holding for 5 seconds before withdrawing. The injection should be virtually painless. If you experience persistent pain, bruising, or redness at injection sites, consult your provider.

When Is the Best Time to Take BPC-157?

Timing of BPC-157 injections is less critical than consistency. Most clinicians recommend taking it at the same time each day to maintain steady tissue levels. The two most common timing strategies are morning dosing (to support daytime activity and recovery) and split dosing (morning and evening) for more sustained exposure.

Some practitioners recommend dosing BPC-157 on an empty stomach based on the theory that food-related insulin spikes may interfere with peptide absorption. However, there is no published research specifically comparing fed versus fasted BPC-157 administration in humans. The practical difference is likely minimal for subcutaneous injection since the peptide enters circulation through subcutaneous tissue rather than the GI tract.

For athletes, timing the injection 30 to 60 minutes before or after training is a common practice. The rationale is that exercise increases blood flow to the targeted tissue, potentially improving local peptide delivery. Again, this is based on logical reasoning rather than controlled studies, but it aligns with general principles of tissue perfusion and drug distribution.

How Long Should a BPC-157 Cycle Last?

Most BPC-157 protocols run for 4 to 8 weeks, which corresponds to the treatment durations used in the majority of animal studies. A 2019 review noted that therapeutic effects in tendon and muscle healing models were typically observed within 10 to 14 days, with maximum benefit seen at 4 to 6 weeks of continuous administration. Longer cycles of 8 to 12 weeks are sometimes used for chronic conditions or slow-healing injuries.

There is no established requirement for "cycling off" BPC-157. Unlike compounds that affect hormonal axes (such as GH secretagogues or anabolic agents), BPC-157 does not appear to produce tolerance, dependence, or hormonal suppression in available research. Some clinicians nonetheless recommend 2 to 4 week breaks between cycles as a general precaution.

The decision to continue, pause, or stop BPC-157 should be based on clinical response. If your symptoms have resolved and the injury has healed, there is no need to continue treatment. If progress has stalled or symptoms persist, your provider may adjust the dose, add a complementary peptide, or investigate other contributing factors.

Should You Take BPC-157 Orally or by Injection?

BPC-157 is available in both injectable and oral forms, and the choice depends primarily on the target condition. Research in the journal Life Sciences demonstrated that BPC-157 is remarkably stable in gastric acid, retaining biological activity after incubation in simulated gastric fluid for up to 24 hours. This unusual stability for a peptide makes oral administration a viable option.

For gut-related conditions (IBS, leaky gut, ulcers, inflammatory bowel issues), oral administration is generally preferred because it delivers the peptide directly to the gastrointestinal lining. Oral doses are typically higher than injectable doses, usually 500mcg to 1mg per day, because some peptide is lost to digestion despite BPC-157's acid stability.

For musculoskeletal injuries, joint pain, tendon healing, and other non-GI applications, subcutaneous injection is the preferred route. Injection ensures reliable bioavailability and allows for targeted delivery near the injury site. Some clinicians use both routes simultaneously, particularly for patients with gut issues who also have musculoskeletal complaints.

What Are the Recommended Doses for Specific Conditions?

The following protocols are based on the research literature and common clinical practice. They are not standardized medical guidelines because no regulatory body has established formal BPC-157 dosing protocols for any human condition. Work with your healthcare provider to determine the most appropriate approach for your situation.

Is BPC-157 Safe at These Doses?

BPC-157 has shown a clean safety profile across hundreds of animal studies at doses up to 10 times the standard therapeutic range. No lethal dose has been established in animal research, which is unusual for a bioactive peptide. A 2020 systematic review in the Journal of Orthopaedic Research confirmed that no significant adverse effects were reported in any published BPC-157 study.

The most commonly reported side effects in clinical practice are mild and transient. These include injection site redness or swelling, mild nausea (more common with oral forms), dizziness, and headache. These typically resolve within the first few days of use.

Serious adverse events have not been documented in published research or clinical reports.

The key safety caveat is sourcing quality. Third-party testing of commercially available BPC-157 products has found significant variability in purity and potency. Contamination with bacterial endotoxins, heavy metals, or other peptide fragments is a real risk with unregulated suppliers.

Always source from a licensed compounding pharmacy or verify third-party testing certificates before using any peptide product.

Frequently Asked Questions About BPC-157 Dosage

Can you take too much BPC-157?

Animal studies have not identified a toxic dose of BPC-157, and no overdose cases have been documented. However, taking more than the recommended dose has not been shown to produce proportionally better results. Stick to the 200 to 500mcg daily range unless your provider specifically recommends otherwise.

Do you need to cycle BPC-157?

There is no research evidence that BPC-157 produces tolerance or requires cycling. Most practitioners recommend 4 to 8 week treatment periods based on the injury healing timeline rather than any pharmacological necessity. Some use it continuously for chronic conditions at lower doses.

How many vials of BPC-157 do you need for a cycle?

For a standard 30-day cycle at 250mcg per day, you need 7.5mg total. One 5mg vial lasts about 20 days, so two 5mg vials cover a full month. At 500mcg per day, you need 15mg total, which equals three 5mg vials or one and a half 10mg vials for 30 days.

Can you mix BPC-157 and TB-500 in the same syringe?

Many practitioners do combine BPC-157 and TB-500 in the same injection for convenience. There are no known chemical incompatibilities between the two peptides, and the combination is widely used in clinical practice. However, some clinicians prefer separate injections to allow for independent dose adjustment.

What happens if you miss a dose?

Missing a single dose is unlikely to significantly impact outcomes. BPC-157's tissue-repair effects are cumulative rather than dependent on maintaining exact plasma levels. Simply take your next scheduled dose as normal.

Do not double up to compensate for a missed dose.

Should you take BPC-157 on rest days?

Yes. Tissue repair and healing continue around the clock, not just during or after exercise. Consistent daily dosing, including rest days, maintains the steady-state tissue concentration needed for optimal healing response.

Skipping rest days would reduce total exposure and potentially slow recovery.